http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016296569-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16e694a83e0a87e09d92f0c1de5b4704
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2400-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-3204
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-3202
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2014-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_affecb0e75375a60754e59b14b62b431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0cc0512acb2f79d501db0450e4c1252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe9d1ad21e7f7e4a040d905d4a5e916c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d49590177dea75cd86eb11cf265588e
publicationDate 2016-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2016296569-A1
titleOfInvention Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid
abstract The present invention relates to the use of a composition comprising bacteria to increase the intestinal production of butyric acid, folic acid or niacin and/or to decrease the intestinal production of succinic acid. Moreover, the present invention relates to the use of said composition for the treatment and/or prevention of an intestinal butyrate- and/or succinate-dependent pathological condition. In particular, for the treatment and/or the prevention of intestinal inflammation, diarrhoea, ulcerative colitis or intestinal colopathies.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11752179-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11751597-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11464814-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400124-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11591416-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110358714-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110358712-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11534468-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019290706-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3379899-A1
priorityDate 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012269865-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011038837-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135444779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399438

Total number of triples: 49.